PTGDS and neoplasm: We also found that the treatment with Fer-1 and DFO could reverse the combined anti-tumor effects of Sorafenib and PTGDS knockdown in PTCL cells (Supplementary Fig. S5), indicating that ferroptosis played important role in the inhibitory effects.